These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31233810)

  • 1. National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice.
    Schelenz S; Owens K; Guy R; Rautemaa-Richardson R; Manuel RJ; Richardson M; Moore C; Enoch DA; Micallef C; Howard P; Agrawal SG; Johnson EM; Muller-Pebody B;
    J Infect; 2019 Aug; 79(2):167-173. PubMed ID: 31233810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.
    Vena A; Bassetti M; Mezzogori L; Marchesi F; Hoenigl M; Giacobbe DR; Corcione S; Bartoletti M; Stemler J; Pagano L; Cornely OA; Salmanton-García J
    Infection; 2024 Feb; 52(1):197-208. PubMed ID: 37656348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.
    Tan BH; Chakrabarti A; Patel A; Chua MMM; Sun PL; Liu Z; Rotjanapan P; Li R; Wahyuningsih R; Chayakulkeeree M; Chen YC;
    Int J Infect Dis; 2020 Jun; 95():471-480. PubMed ID: 31945491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam.
    Hieu VN; Hiep NL; Hang LM; Lau-Goodchild BA; Van Duong N; Linh NT; Beardsley J; Dat VQ
    Med Mycol; 2024 Aug; 62(8):. PubMed ID: 39122653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national survey on fungal infection diagnostic capacity in the clinical mycology laboratories of tertiary care hospitals in China.
    Wang H; Wang Y; Yang QW; Ni YX; Lin LK; Luo YP; Sun ZY; Li M; Wu WJ; Zhang QQ; Su DH; Yu H; Kang M; Xu HP; Liu W; Yang Q; Jian C; Guo LN; Yang WH; Xiao M; Hsueh PR; Xu YC
    J Microbiol Immunol Infect; 2020 Dec; 53(6):845-853. PubMed ID: 32334978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
    Bellanger AP; Persat F; Foulet F; Bonnal C; Accoceberry I; Angebault C; Angoulvant A; Augereau O; Bailly E; Bert F; Bonhomme J; Bouchara JP; Bougnoux ME; Bourdeau P; Bouteille B; Brun S; Brunet K; Camin-Ravenne AM; Cassaing S; Chouaki T; Cornet M; Costa D; Desbois N; Dorin J; Fekkar A; Fiacre A; Fréalle E; Gangneux JP; Guillot J; Guitard J; Hasseine L; Huguenin A; Lachaud L; Larréché S; Lavergne RA; Le Gal S; Le Govic Y; Letscher-Bru V; Machouart M; Mazars E; Nourrisson C; Paugam A; Ranque S; Risco-Castillo V; Sasso M; Sautour M; Sendid B; Senghor Y; Botterel F; Dannaoui E
    J Mycol Med; 2020 Jun; 30(2):100970. PubMed ID: 32334948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Austrian landscape of diagnostic capacity and access to treatment for invasive fungal infections.
    Salmanton-García J; Hoenigl M; Salzer HJF; Lackner M; Prattes J; Dichtl K; Winkler-Zamani M; Krause R; Stemler J; Lass-Flörl C; Cornely OA; Willinger B
    Mycoses; 2023 Dec; 66(12):1056-1063. PubMed ID: 37592370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.
    Paige E; Haywood P; Xie M; Worth L; Thursky K; Urbancic K; Bajel A; Slavin M
    Leuk Lymphoma; 2019 Oct; 60(10):2373-2383. PubMed ID: 31096813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal.
    Fernandes R; Sabino R; Cunha C; Cornely OA; Carvalho A; Salmanton-García J;
    Mycopathologia; 2024 Jan; 189(1):15. PubMed ID: 38265528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society.
    Ocansey BK; Dadzie EA; Eduful SK; Agyei M; Osei MM; Puplampu P; Asamoah I; Oladele RO; Osaigbovo II; Afriyie-Mensah JS; Opintan JA; Essien-Baidoo S; Chakrabarti A; Hoenigl M; Denning DW; Richardson MD
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36073757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.
    Colombo AL; de Almeida Júnior JN; Slavin MA; Chen SC; Sorrell TC
    Lancet Infect Dis; 2017 Nov; 17(11):e344-e356. PubMed ID: 28774702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.
    Chindamporn A; Chakrabarti A; Li R; Sun PL; Tan BH; Chua M; Wahyuningsih R; Patel A; Liu Z; Chen YC; Chayakulkeeree M
    Med Mycol; 2018 Jun; 56(4):416-425. PubMed ID: 29036605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model.
    Oladele RO; Osaigbovo II; Ayanlowo OO; Otu AA; Hoenigl M; Cornely OA; Chakrabarti A; Denning DW
    Mycoses; 2019 Jan; 62(1):16-21. PubMed ID: 30184285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
    Kovács R; Majoros L; Stemler J; Cornely OA; Salmanton-García J
    Ther Adv Infect Dis; 2023; 10():20499361231219315. PubMed ID: 38116297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of invasive fungal diseases in pediatric patients.
    Pana ZD; Vikelouda K; Roilides E
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1203-1213. PubMed ID: 27681004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Training should be the first step toward an antifungal stewardship program.
    Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.
    Salmanton-García J; Hoenigl M; Gangneux JP; Segal E; Alastruey-Izquierdo A; Arikan Akdagli S; Lagrou K; Özenci V; Vena A; Cornely OA
    Lancet Microbe; 2023 Jan; 4(1):e47-e56. PubMed ID: 36463916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.